|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net loss attributable to common stockholders | |
| Net loss and adjustment attributable to redeemable non-controlling interest | |
| Net loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Stock-based compensation | |
| Net accretion of discounts and premiums on marketable securities | |
| Changes in operating assets and liabilities: | |
| Accounts payable | |
| Accrued and refund liabilities | |
| Net cash used in operating activities | |
| Cash flows from investing activities: | |
| Purchases of marketable securities | |
| Maturities of marketable securities | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Proceeds from issuance of redeemable convertible Preferred Units, net | |
| Net cash used in provided by (used in) financing activities | |
| Net increase (decrease) in cash, cash equivalents and restricted cash | |
| Cash, cash equivalents and restricted cash at beginning of year | |
| Cash, cash equivalents and restricted cash at end of year | |
| Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets: | |
| Cash and cash equivalents |
Loading...
